← Leaderboards
Jose M. Garcia
Va Puget Sound Healthcare System
$4,005,580
Attributed
$8,572,046
Total exposure
8
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2009–25$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,572,046 · 5
VA$0 · 3
By mechanism
R01$8,000,393 · 3
R21$415,153 · 1
R03$156,500 · 1
I01$0 · 3
Top collaborators
- Shehzad Basaria11 shared
- Egidio Del Fabbro5 shared
- Sina A Gharib2 shared
Most similar at Va Puget Sound Healthcare System
Same institution · by research overlap
- Glenn Klute$0
- Kristina Anne Crothers$11,792,590
- William R. Ledoux$2,146,767
- Nicole Faron Liachko$2,745,815
- David H Au$4,264,903
Others in their field
Top investigators on “Quality Of Life”
- Gary D Acton · University Of California-Davis$320,373,312
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Gregory H Reaman · National Childhood Cancer Foundation$264,644,476
- David R. Weir · University Of Michigan At Ann Arbor$263,050,576
- Richard K. Wilson · Washington University$198,912,538
Research focus
Quality Of LifeMalignant NeoplasmsMuscle StrengthBody CompositionAffectCancer TherapyEffective TherapyDiagnosisMuscle FunctionFatty Acid Glycerol EstersPrevalenceFatigueGhrelinMusclePathway InteractionsHormonesPreventMediatingHigh PrevalenceCancer PatientMuscle FormEatingHospitalizationHealth Care Costs
Grant awards (34)
Improving cancer-related fatigue, sexual dysfunction and quality of life in older men with cancer and androgen deficiency$661,925
R01 · FY2025 · AG · contact PI
SArcopenia in Men with Prostate Cancer undergoing ADT (SAP-ADT)$648,806
R01 · FY2025 · CA · contact PI
Improving Patient-Important Outcomes with Testosterone Replacement in Hypogonadal Men with a Prior History of Cancer$517,115
R01 · FY2025 · CA · contact PI
The Role of Ghrelin and the GHSR-1a receptor in Sarcopenic Obesity$0
I01 · FY2025 · VA · contact PI
SArcopenia in Men with Prostate Cancer undergoing ADT (SAP-ADT)$651,680
R01 · FY2024 · CA · contact PI
Improving Patient-Important Outcomes with Testosterone Replacement in Hypogonadal Men with a Prior History of Cancer$631,770
R01 · FY2024 · CA · contact PI
The Role of Ghrelin and the GHSR-1a receptor in Sarcopenic Obesity$0
I01 · FY2024 · VA · contact PI
Improving cancer-related fatigue, sexual dysfunction and quality of life in older men with cancer and androgen deficiency$673,710
R01 · FY2023 · AG · contact PI
Improving Patient-Important Outcomes with Testosterone Replacement in Hypogonadal Men with a Prior History of Cancer$125,176
R01 · FY2023 · CA · contact PI
The Role of Ghrelin and the GHSR-1a receptor in Sarcopenic Obesity$0
I01 · FY2023 · VA · contact PI
Improving Patient-Important Outcomes with Testosterone Replacement in Hypogonadal Men with a Prior History of Cancer$643,552
R01 · FY2022 · CA · contact PI
The Role of Ghrelin and the GHSR-1a receptor in Sarcopenic Obesity$0
I01 · FY2022 · VA · contact PI
Improving cancer-related fatigue, sexual dysfunction and quality of life in older men with cancer and androgen deficiency$673,599
R01 · FY2021 · AG · contact PI
The Role of Ghrelin and the GHSR-1a receptor in Sarcopenic Obesity$0
I01 · FY2021 · VA · contact PI
Improving cancer-related fatigue, sexual dysfunction and quality of life in older men with cancer and androgen deficiency$679,841
R01 · FY2020 · AG · contact PI
Improving Patient-Important Outcomes with Testosterone Replacement in Hypogonadal Men with a Prior History of Cancer$663,748
R01 · FY2020 · CA · contact PI
The Role of Ghrelin and the GHSR-1a receptor in Sarcopenic Obesity$0
I01 · FY2020 · VA · contact PI
Improving Patient-Important Outcomes with Testosterone Replacement in Hypogonadal Men with a Prior History of Cancer$720,928
R01 · FY2019 · CA · contact PI
Improving cancer-related fatigue, sexual dysfunction and quality of life in older men with cancer and androgen deficiency$708,543
R01 · FY2019 · AG · contact PI
Mechanisms of action of ghrelin in muscle and adipose tissue in cancer cachexia$0
I01 · FY2019 · VA · contact PI
Mechanisms of action of ghrelin in muscle and adipose tissue in cancer cachexia$0
I01 · FY2018 · VA · contact PI
Mechanisms of action of ghrelin in muscle and adipose tissue in cancer cachexia$0
I01 · FY2017 · VA · contact PI
Mechanisms of action of ghrelin in muscle and adipose tissue in cancer cachexia$0
I01 · FY2016 · VA · contact PI
Mechanisms of action of ghrelin in muscle and adipose tissue in cancer cachexia$0
I01 · FY2016 · VA · contact PI
The Role of Ghrelin in Cancer Cachexia$0
I01 · FY2014 · VA · contact PI
Mechanisms of action of ghrelin in muscle and adipose tissue in cancer-related ca$0
I01 · FY2013 · VA · contact PI
The Role of Ghrelin in Cancer Cachexia$0
I01 · FY2013 · VA · contact PI
The role of ghrelin and the ghrelin receptor GHSR1a in sarcopenia of aging$78,250
R03 · FY2012 · AG · contact PI
Mechanisms of action of ghrelin in muscle and adipose tissue in cancer-related ca$0
I01 · FY2012 · VA · contact PI
The role of ghrelin and the ghrelin receptor GHSR1a in sarcopenia of aging$78,250
R03 · FY2011 · AG · contact PI
The role of ghrelin in cisplatin-induced infertility$191,858
R21 · FY2010 · HD · contact PI
The role of ghrelin in cisplatin-induced infertility$223,295
R21 · FY2009 · HD · contact PI
Mechanisms of action of ghrelin in muscle and adipose tissue in cancer-related ca$0
I01 · FY2009 · VA · contact PI
The Role of Ghrelin in Cancer Cachexia$0
I01 · FY2009 · VA · contact PI